Welcome to GENI

Message from the Chair Professor Louis Niessen and the Chief Executive Officer, Dr Kathryn Antioch

 Dr Kathryn Antioch KALN

Welcome to GENI, a not for profit international association that aims to drive international mechanisms to integrate Clinical Practice Guidelines (CPGs), clinical and cost effectiveness evidence into national decision making and clinical practice. A key imperative is to forge links with national bodies that set standards, regulation and funding processes such as governments and insurance bodies.

GENI has a unique focus on achieving both clinical and cost effectiveness in healthcare delivery and equity in related funding world-wide.  GENI’s vision is being implemented by an international Board of experts from the OECD, World Bank, Australia, UK, USA, Canada, China, NZ, Sweden and Denmark. The current reach of GENI Board member’s work is extensive ranging from impacts at the point of health care delivery, and extending through to national Governments and Parliaments.

To achieve GENI’s key objectives, we are Identifying key medical and surgical priority areas worldwide; stimulating funding opportunities to support the work and encouraging collaboration worldwide in relevant economic and clinical methodologies.

Click here for GENI’s Agenda.

Achieving participation worldwide

To work towards achieving its goals GENI is collaborating with Health Economic Associations, Governments, Parliaments, guideline development agencies, WHO, World Bank, United Nations, OECD, medical and surgical associations, universities, foundations, national hospital associations, health service delivery organisations and other health economists and health care professionals.

GENI has established a LinkedIn® Group to facilitate collaboration and share knowledge and ideas. You can join the GENI LinkedIn® Group by clicking on the GENI button below.

We look forward to seeing the GENI network grow and sharing insights and approaches to improving evidenced-based care, along with improvements in equity in related national funding and regulation scenarios. We are very grateful for the leadership provided by the past GENI  Chairman, Professor Michael Drummond who presided over the Board from 2006 to 2023.

Professor Louis Niessen and Dr Kathryn Antioch